Novartis Direct Buyers' Attys Get $42M In Drug Delay Case
By Gina Kim · July 26, 2023, 4:06 PM EDT
A New York federal judge awarded counsel for direct purchasers of Novartis' hypertension medication $42.15 million in attorney fees, according to an order Tuesday granting final approval of a $126 million...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login